logo

For the Inventor, By the Inventor

Rahway, NJ, United States of America

Patrick J Cassidy

This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignee: Merck + Co., Inc.. Active years: 1979-1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick J Cassidy. Retrieved from https://idiyas.com/inventor/patrick-j-cassidy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:

goldMedal9 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1979-1981

Loading Chart...
9 patents (USPTO):Explore Patents
1. 4304859 - Process for producing A73A, a new Efrotomycin-like antibiotic in (1981-12-08),
2. 4264736 - Antibiotic 890A.sub.10 (1981-04-28),
3. 4264735 - Method of producing antibiotic 890A.sub.9 (1981-04-28),
4. 4262002 - Discovery of A73A, a new efrotomycin-like antibiotic in fermentation (1981-04-14),
5. 4235967 - Process for producing antibiotics by cultivation of Streptomyces (1980-11-25),
6. 4207395 - Process for deacylating (1980-06-10),
7. 4168202 - Process for producing antibiotics (1979-09-18),
8. 4162324 - Antibiotics 890A.sub.1 and 890A.sub.3 (1979-07-24),
9. 4141986 - Antibiotics 890A.sub.2 and 890A.sub.5 (1979-02-27),

Title: Innovator Spotlight: Patrick J. Cassidy of Rahway, NJ

Introduction: Patrick J. Cassidy, a notable inventor based in Rahway, New Jersey, has made significant contributions to the field of pharmaceuticals, particularly in the development of new antibiotic agents. With a total of nine patents to his name, Cassidy's work has been instrumental in advancing antimicrobial therapies.

Latest Patents: Among his latest innovations are two groundbreaking patents. The first is for a process for producing A73A, a novel Efrotomycin-like antibiotic. This antibiotic, derived from the microbial species Streptomyces viridifaciens MA-4864 (ATCC 31495), demonstrates both antibacterial properties and growth-permittant activity. His second recent patent concerns the method of producing antibiotic 890A.sub.9, which shows efficacy against a broad spectrum of bacteria, including both gram-positive and gram-negative strains. This antibiotic is produced through the fermentation of specific Streptomyces species in optimized media.

Career Highlights: Patrick J. Cassidy is currently employed at Merck & Company, Inc., a leading global healthcare company renowned for its innovative drug development. Throughout his career, Cassidy has focused on research that enhances public health through the creation of effective antibiotic solutions.

Collaborations: Patrick has collaborated with esteemed colleagues, including Sebastian Hernandez and Robert T. Goegelman. Together, they have worked on various research projects that push the boundaries of antibiotic development and contribute to the fight against antibiotic resistance.

Conclusion: Patrick J. Cassidy is a distinguished inventor whose work in antibiotic development has had a profound impact on medical science. With his patents and collaborative efforts, he continues to inspire future innovations in the pharmaceutical industry, striving for breakthroughs that safeguard public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…